J B CHEMICALS AND PHARMA

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Amalgamation/Merger

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Execution of a Trade Mark License Agreement with Novartis Innovative Therapies AG, Switzerland for a portfolio of select ophthalmology brands and promotion & distribution agreement with Novartis Healthcare Private Limited, India for the same select ophthalmology brands.

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about update on Acquisition of Brands and Related Assets from Sanzyme Private Limited

JB Chemicals & Pharmaceuticals Limited has informed the Exchange about Acquisition of a portfolio of brands, for use and commercialization within India, from Sanzyme Private Limited

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that the board of directors of the company, at its meeting held on November 04, 2015 has approved the acquisition of 21,94,030 (51%) ordinary shares in Biotech Laboratories (Pty.) Ltd., South Africa ( Biotech ), held by Africa Biopharma Investments (Pty.) Ltd. by a company's subsidiary, subject to necessary approvals and definitive agreements to be entered into with the seller. The company's subsidiary J.B. Healhcare Pvt. Ltd. presently holds 21,07,990 (49%) ordinary shares in Biotech, besides 175,591 Non-Redeemable Convertible P

JB Chemicals & Pharmaceuticals Limited has informed the Exchange that the Hon'ble Bombay High Court has sanctioned the Scheme of Amalgamation and Arrangement between Jyotindra Mody Holdings Private Limited and Ansuya Mody Securities Private Limited and Dinesh Mody Securities Private Limited and Kumud Mody Securities Private Limited and Shirish B. Mody Investments Private Limited and Bharati S. Mody Investments Private Limited and J. B. Chemicals & Pharmaceuticals Limited and their respective shareholders under Sections 391 to 394 read with Sections 100 to 103 of the Companies Act, 1956 and Sec

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that "the final hearing of the Company Petition filed by J. B. Chemicals & Pharmaceuticals Ltd. for seeking sanction of the Scheme of Amalgamation was held on 2nd February, 2007. At the said hearing the Hon'ble High Court of Judicature of Bombay at Mumbai has sanctioned the Scheme of Amalgamation of Lekar Healthcare Ltd. with J. B. Chemicals & Pharmaceuticals Ltd".

Jb Chemicals & Pharmaceuticals Ltd. has informed the Exchange that Board of Directors in its meeting held on May 10, 2006 have approved amalgamation of Lekar Healthcare Ltd., wholly owned subsidiary into J.B. Chemicals & Pharmaceuticals Ltd., the holding Company.